Skip to content

TOLERANCE OF MILK FEEDS IN PRETERM, VERY LOW BIRTH WEIGHT BABIES: THE USE OF GLYCERINE SUPPOSITORIES

TOLERANCE OF MILK FEEDS IN PRETERM, VERY LOW BIRTH WEIGHT BABIES: THE USE OF GLYCERINE SUPPOSITORIES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-000302-31-GB
Enrollment
28
Registered
2005-03-31
Start date
2005-04-25
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The problem is inability to sustain enteral feeding in very low birth weight babies due to feed intolerance. The necessity for parenteral feeding creates risk of sepsis, cholestasis,increased oxygen requirement and abdominal distension

Interventions

Product Name: Glycerin 250mg suppository Pharmaceutical Form: Suppository

Sponsors

NHS Lanarkshire, Primary Care Operating Division
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion and Exclusion Criteria The study group will include all preterm babies born at Wishaw General Hospital at less than 32 weeks’ gestation. Babies are stratified in two main groups based on their gestational age- a) =65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Babies will be excluded from the study if they have major dysmorphic features, are found to have a structural gastrointestinal anomaly, develop Necrotising Enterocolitis or suffer perinatal hypoxic ischaemic encephalopathy.

Design outcomes

Primary

MeasureTime frame
Primary end point(s): Achievement of full enteral feeds. Development of Necrotising Enterocolitis. ; Main Objective: To shorten the time to first achievment of full enteral feeding and so reduce the risk associated with parenteral feeding. ; Secondary Objective: Secondary research questions: Is the use of glycerine suppositories associated with a decrease in - NEC, - Sepsis, - Oxygen requirement, - Episodes of abdominal distension, or an increase in rate of growth?

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026